Only healthy women with uncomplicated pregnancies who subsequently gave birth to healthy single infants weighing more than 2500 grams were included. They were followed by serial sampling usually every second week from between the 28 th to 32nd week of pregnancy until delivery. The total number of patients in this group was 45. In order to study the day-to-day Variation, two samples were taken with 24 hours intervals in a number of patients, totally 61 duplicate samples. The study has been performed during the time period 1. 1. 1973 to 31. 12. 1974 . During this period the total number of deliveries was 4343, with a perinatal mortality of 1.4%. The material studied, consists of 656 women which were judged s risk-pregnancies. In these patients one or more analyses of all three parameters have been performed from the 36 week of pregnancy. Usually one to two assays have been performed each week. In some risk pregnancies daily estriol assays have been performed on clinical indications but only those assays have been included in the study where HCS and CAP estimations have been performed simultaneously. Patients with Rh-immunization and twin pregnancies have been excluded from the material. The material has been divided into two groups.
Normal infant group (540 patients): Pregnancy with no fetal complications at delivery. APGAR score > 7 one minute after delivery. Normal birth weight. 
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A. Cardiotocographic recordings indicating fetal distress during delivery and APGAR score < 7 one minute after delivery (21 patients). B. Pregnancy operatively terminated due to fetal distress (60 patients of which 37 were delivered by cesarean section and 23 by vacuum extraction). C. Birth weight < 2 S.D. from the mean according to gestational age (35 patients).
Methods
Daily urinary Output of estrogens were measured according to HAINSWORTH and HALL [8] . The determinations were performed on a TECHNICON autoanalyzer. Cystine aminopeptidase (CAP) in serum was measured at 37 °C with the method described by PEETERS [16] using 1-cystine-bis-paranitroanilide s Substrate. Human chorionic somatomammotrophin (HCS) was measured according to LINDBERG et al [12] with use of the Phadebas HCS Kit from PHARMACIA Diagnostics. 
Normal pregnancy (reference group)
The results obtained in serial samples during normal pregnancies from the 28th week of pregnancy are seen in Fig. 1-3 . The day-to-day Variation calculated s the coefficient of Variation was for CAP assays 8.5%, for HCS assays 7.3% and for estriol assays 16.0%.
High risk pregnancy
The frequency of low biochemical parameters in the normal and distressed infant group are presented in Tab. I. A statistical analysis using FISHER'S exact test [2] demonstrates that all three parameters are valuable in predicting fetal complications in risk pregnancies. Estriol assays seem to be somewhat superior to CAP and HCS in this respect, the differenceishowevernot statistically signiflcant. Tab. I. The incidence of low biochemical parameters in the normal and in the distressed infant group. Tab. II. The incidence of low biochemical levels with two or three combined tests. A statistical analysis was performed using FISHER'S exact test in order to evaluate if estriol assays combined either with HCS or CAP gave more Information than only estriol assays. The results obtained showed that estriol combined with CAP gave a significant increase in the number of detected distressed infants (P = 0.003). Similar results were also found concerning HCS combined with estriol comparedto estriol assays (P = 0.04). A combination of all three tests did not significantly increase the number of detected risk deliveries compared to the combination estriol -CAP or estriol -HCS. According to the results obtained, a combination of the serum assays CAP -HCS predicted the same incidence of distressed infants äs urinary estriol assays alone.
Number of patients

Discussion and conclusion
A number of studies have repeatedly confirmed that the quantity of maternal estriol excretion in urine is a reliable index of the function of the fetoplacental unit. The method has however some disadvantages, mainly the inaccuracy of the 24 hours sampling. Even with careful urine collection the individual day-to-day Variation is rather pronounced (the coefficient of variations was 16% in the present study). Many reports also indicate that estriol assays not always reflect the condition of the feto-placental unit [6, 15, 19] , and much research has during the last decade been directed towards new methods for evaluating the fetoplacental unit. In recent years much attention has been directed towards the determination of HCS äs a possible mean of monitoring the placental function [1, 11, 13, 20, 21] . Among the numerous studies on this subject a recently published paper by SPELLACY et al. [21] is the most convincing concerning the clinical value of HCS-assays. In a large randomized controlled prospective study they demonstrated the usefulness of routine prenatal HCS measurements in the management of high risk pregnancies. They obtained a significantly reduced fetal death rate in the group controlled by HCS assays compared with a control group. Concerning CAP assays the results are more conflicting. WATSON et al. [23] , who compared the usefulness of CAP, HCS, heat-stable alkaline phosphatase (HSAP) and, 17-j3-estradipl in plasma and urinary estriol excretion found HSAP and CAP to be the least sensitive indicators of feto-placental dysfunction in twelve patients studied. In eightof these patients, however, only mild feto-placental dysfunction was present, ähd it is therefore difficult to evaluate their results. CURZEN and VARMA [7] who compared CAP and urinary estriol assays concluded that CAP was of no value in predicting the condition of the feto-placental unit. Other authors [3, 4, 9, 17, 19, 22] Comparative studies using all three parameters are scanty. KRISTENSEN et al. [5] compared HCS, CAP and urinary estriol excretion in pregnancies complicated with essential hypertension and preeclampsia. They concluded that a combination of all three tests contribute to ,a more reliable Information in pregnancies complicated with preeclampsia. The present study confirms that all three tests are valuable in predicting the condition of the feto-placental unit in risk pregnancies. When comparing all three methods it seems that estriol assays are somewhat better than HCS and CAP assays in predicting the condition of the infänt at birth, the difference is however not statistically significant. Nevertheless it must be emphasized that estriol assays which reflect the condition of the whole feto-placental unit cannot be substituted by HCS or CAP assays which only reflect the condition of the placenta. If estriol assays are combined with CAP or HCS assays a somewhat better reliability is obtained. The same conclusions have recently been made by SCHMID [20] comparing estriol and estriol-HCS assays. Urinary estriol assays seem to give the most reliable Information concerning the condition of the fetus among the methods used in the present study. Estriol assays are however inconvenient to use äs a screening procedure for detecting risk pregnancies, partly because of the practical problems with the urine sampling, partly because of the large day-today Variation. The flrst problem can be overcome with plasma estriol assays. It is however still questionable if plasma assays of estriol is more reliable than urinary assays [10, 14] . HCS and CAP assays are more suitable for routine use in large scale and if they are used simultaneously at least the same number of distressed fetuses will be detected äs with estriol assays, HCS and CAP estimations are very easy to perform and need only a venous blood sample which can be taken on out-patient clinics and CAP-assays need rather ordinary equipment. Even if both tests are reflecting the condition of the placenta it seems preferable to use them simultaneously äs they are overlapping each other to a rather small extent, which may indicate that they are reflecting different parts of the placental function. As CAP and HCS only assess the conditions of the placenta the risk pregnancies detected in this way should thereafter be controlled using more sensitive indicators of fetal well-being, i.e. estriol assays, ultrasound measurements of the biparietal diameter and cardiotocographic recordings in order to estimate the optimal time for delivery. Management of pregnancies in this way might decrease the perinatal mortality further, especially the number of prenatal deaths which at present are responsible for a large part of the perinatal deaths in füll term pregnancies.
Summary
Cystine aminopeptidase (CAP) and human chorionic somatomammotrophin (HCS) activity in maternal serum and urinary estriol excretion have been followed simultaneously in normal and risk-pregnandes to study if CAP and HCS are comparable to estriol assays in predicting the condition of the fetus at birth and to study if a combination of tests give more accurate Information concerning the fetoplacental unit than only one test. The results were äs follows:
Normal pregnancy The material consists of 45 patients which were followed every second week from the 28-32 week of pregnancy until term with serial assays of CAP, HCS and urinary estriol. (Fig. 1-3 ). The coefficient of Variation was for CAP 8,5 per cent, for HCS 7.3 per cent and for urinary estriol 16.0 per cent.
High-risk-pregnancy
The material has been divided into two groups, a normal infant group consisting of 540 patients and a distressed infant group consisting of 116 patients. Low biochemical parameters have been defined äs follows: HCS < 4 mg/1 serum from 36 week of pregnancy, CAP < 80 nkat/1 (4.8 U/l) serum from 36 week of pregnancy, urinary estriol excretion < 70 (20 mg)/24 hours week 36-37 and < 84 (24 mg)/24 hours from 38 week of pregnancy. The frequency of low biochemical parameters in the normal infant group was 8.7% for estriol, 5.4% for CAP and 5.6% for HCS assays. The corresponding figures in the distressed infant group was 30, 23 and 18% respectively. The frequency of low biochemical parameters in the normal and the infant complication group with different combinations of tests has also been calculated. The results obtained demonstrated that estriol combined either with CAP or HCS gave a significant increase in the capacity to predict fetal complications compared to estriol assays alone. A combination of all three tests did not significantly increasethenumberof detected distressed fetuses compared to a combination of two parameters. The following conclusions can be made: All three methods are valuable in predicting fetal complications. Estriol assays seem to be somewhat superior to CAP and HCS in this respect. Urinary estriol assays should be used äs the primary biochemical test for evaluating the feto-placental unit. If estriol assays are combined with CAP or HCS an increase in the number of detected distressed fetuses was obtained compared to estriol assays alone. If CAP was combined with HCS this combination was at least äs informative äs estriol assays alone, and this combination should preferably beused äs screening-test to detect pregnancies where placental insufficiency may occur.
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Grossesse normale
Le materiel concerne 45 parturientes qui ont ete suivies toutes les deux semaines entre la 28-32eme semaine de la grossesse et le terme par des series de tests de CAP, HCS et oestriol urinaire (Fig. l -3 
